Literature DB >> 11906087

Seroprevalence of anti-Encephalitozoon antibodies in Spanish immunocompetent subjects.

C del Aguila1, C Rueda, C De la Camara, S Fenoy.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11906087     DOI： 10.1111/j.1550-7408.2001.tb00459.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN： 1066-5234            Impact factor:   3.346


× No keyword cloud information.
  5 in total

1.  Encephalitozoon cuniculi Genotype II Concentrates in Inflammation Foci.

Authors:  Klára Brdíčková; Bohumil Sak; Nikola Holubová; Dana Květoňová; Lenka Hlásková; Marta Kicia; Żaneta Kopacz; Martin Kváč
Journal:  J Inflamm Res       Date:  2020-09-25

2.  Microsporidiosis acquired through solid organ transplantation: a public health investigation.

Authors:  Susan N Hocevar; Christopher D Paddock; Cedric W Spak; Randall Rosenblatt; Hector Diaz-Luna; Isabel Castillo; Sergio Luna; Glen C Friedman; Suresh Antony; Robyn A Stoddard; Rebekah V Tiller; Tammie Peterson; Dianna M Blau; Rama R Sriram; Alexandre da Silva; Marcos de Almeida; Theresa Benedict; Cynthia S Goldsmith; Sherif R Zaki; Govinda S Visvesvara; Matthew J Kuehnert
Journal:  Ann Intern Med       Date:  2014-02-18       Impact factor: 25.391

3.  Production and characterization of monoclonal antibodies against Encephalitozoon intestinalis and Encephalitozoon sp. spores and their developmental stages.

Authors:  Fernando Izquierdo; Hercules Moura; Fernando Jorge Bornay-Llinares; Rama Sriram; Carolina Hurtado; Ángela Magnet; Soledad Fenoy; Govinda Visvesvara; Carmen Del Aguila
Journal:  Parasit Vectors       Date:  2017-11-09       Impact factor: 3.876

4.  Seropositivity for Enterocytozoon bieneusi, Czech Republic.

Authors:  Bohumil Sak; Zuzana Kucerova; Martin Kvac; Dana Kvetonova; Michael Rost; Evan W Secor
Journal:  Emerg Infect Dis       Date:  2010-02       Impact factor: 6.883

5.  Microsporidia and its relation to Crohn's disease. A retrospective study.

Authors:  Juan C Andreu-Ballester; Carlos Garcia-Ballesteros; Victoria Amigo; Ferran Ballester; Rafael Gil-Borrás; Ignacio Catalán-Serra; Angela Magnet; Soledad Fenoy; Carmen del Aguila; Jose Ferrando-Marco; Carmen Cuéllar
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.